The functional genomics of guanylyl cyclase/natriuretic peptide receptor-A: Perspectives and paradigms

FEBS Journal

Volumn 278, Issue 11, 2011, Pages 1792-1807

  Pandey, Kailash N ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

cardiac hypertrophy; functional genomics; guanylyl cyclase receptor; hypertension; natriuretic peptides

Indexed keywords

ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; ATRIAL NATRIURETIC FACTOR ANTAGONIST; BRAIN NATRIURETIC PEPTIDE; NATRIURETIC PEPTIDE RECEPTOR A; NATRIURETIC PEPTIDE RECEPTOR B; NATRIURETIC PEPTIDE TYPE C;

AMINO ACID SEQUENCE; ARTERIAL PRESSURE; BIOLOGICAL ACTIVITY; BLOOD PRESSURE REGULATION; BODY FLUID; DIURESIS; ENDOCYTOSIS; ESSENTIAL HYPERTENSION; FLUID BALANCE; FUNCTIONAL GENOMICS; GENE; GENE DISRUPTION; GENE FUNCTION; GENE MUTATION; GENETIC ASSOCIATION; GLOMERULUS FILTRATION RATE; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HUMAN; INTRACELLULAR SIGNALING; KIDNEY BLOOD FLOW; KIDNEY CELL; LIGAND BINDING; MOLECULAR PATHOLOGY; NONHUMAN; NPPA GENE; NPPB GENE; NPR1 GENE; PATHOPHYSIOLOGY; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RENAL PROTECTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE DISTRIBUTION; VASCULAR SMOOTH MUSCLE;

ANIMALS; CARDIOVASCULAR DISEASES; GENOMICS; GUANYLATE CYCLASE; HUMANS; HYPERTENSION; POLYMORPHISM, GENETIC; RECEPTORS, ATRIAL NATRIURETIC FACTOR; SIGNAL TRANSDUCTION;

EID: 79956226843     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2011.08081.x     Document Type: Review

References (170)

1. de Bold AJ, Borenstein HB, Veress AT, &, Sonnenberg H, (1981) A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 28, 89-94. (Pubitemid 11184926)
2. de Bold AJ, (1985) Atrial natriuretic factor: a hormone produced by the heart. Science 230, 767-770. (Pubitemid 16193965)
3. Brenner BM, Ballermann BJ, Gunning ME, &, Zeidel ML, (1990) Diverse biological actions of atrial natriuretic peptide. Physiol Rev 70, 665-699. (Pubitemid 20196047)
4. Levin ER, Gardner DG, &, Samson WK, (1998) Natriuretic peptides. N Engl J Med 339, 321-328. (Pubitemid 28366422)
5. Pandey KN, (2005) Biology of natriuretic peptides and their receptors. Peptides 26, 901-932. (Pubitemid 40725366)
6. Garbers DL, Chrisman TD, Wiegn P, Katafuchi T, Albanesi JP, Bielinski V, Barylko B, Redfield MM, &, Burnett JC Jr, (2006) Membrane guanylyl cyclase receptors: an update. Trends Endocrinol Metab 17, 251-258. (Pubitemid 44164281)
7. Pandey KN, (2008) Emerging roles of antriuretic peptides and their receptors in pathophysiology of hypertension and cardiovascular regulation. J Am Soc Hypertens 2, 210-226.
8. Gardner DG, (2003) Natriuretic peptides: markers or modulators of cardiac hypertrophy? Trends Endocrinol Metab 14, 411-416. (Pubitemid 37392213)
9. Richards AM, (2007) Natriuretic peptides: update on peptide release, bioactivity, and clinical use. Hypertension 50, 25-30. (Pubitemid 46986002)
10. Vasan RS, Benjamin EJ, Larson MG, Leip EP, Wang TJ, Wilson PW, &, Levy D, (2002) Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study. JAMA 288, 1252-1259. (Pubitemid 35001328)
11. Lucas KA, Pitari GM, Kazerounian S, Ruiz-Stewart I, Park J, Schulz S, Chepenik KP, &, Waldman SA, (2000) Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev 52, 375-414.
12. Tremblay J, Desjardins R, Hum D, Gutkowska J, &, Hamet P, (2002) Biochemistry and physiology of the natriuretic peptide receptor guanylyl cyclases. Mol Cell Biochem 230, 31-47. (Pubitemid 34257240)
13. Drewett JG, &, Garbers DL, (1994) The family of guanylyl cyclase receptors and their ligands. Endocr Rev 15, 135-162. (Pubitemid 24129181)
14. McGrath MF, &, de Bold AJ, (2005) Determinants of natriuretic peptide gene expression. Peptides 26, 933-943. (Pubitemid 40725367)
15. Rosenzweig A, &, Seidman CE, (1991) Atrial natriuretic factor and related peptide hormones. Annu Rev Biochem 60, 229-255.
16. Yan W, Wu F, Morser J, &, Wu Q, (2000) Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme. Proc Natl Acad Sci USA 97, 8525-8529. (Pubitemid 30639706)
17. Thibault G, Amiri F, &, Garcia R, (1999) Regulation of natriuretic peptide secretion by the heart. Annu Rev Physiol 61, 193-217. (Pubitemid 29143169)
18. Sudoh T, Minamino N, Kangawa K, &, Matsuo H, (1988) Brain natriuretic peptide-32: N-terminal six amino acid extended form of brain natriuretic peptide identified in porcine brain. Biochem Biophys Res Commun 155, 726-732.
19. Seilhamer JJ, Arfsten A, Miller JA, Lundquist P, Scarborough RM, Lewicki JA, &, Porter JG, (1989) Human and canine gene homologs of porcine brain natriuretic peptide. Biochem Biophys Res Commun 165, 650-658. (Pubitemid 20025571)
20. Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, Shirakami G, Jougasaki M, Obata K, Yasue H, et al. (1991) Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 87, 1402-1412.
21. Vellaichamy E, Khurana ML, Fink J, &, Pandey KN, (2005) Involvement of the NF-kappa B/matrix metalloproteinase pathway in cardiac fibrosis of mice lacking guanylyl cyclase/natriuretic peptide receptor A. J Biol Chem 280, 19230-19242. (Pubitemid 41379630)
22. Grepin C, Dagnino L, Robitaille L, Haberstroh L, Antakly T, &, Nemer M, (1994) A hormone-encoding gene identifies a pathway for cardiac but not skeletal muscle gene transcription. Mol Cell Biol 14, 3115-3129. (Pubitemid 24132725)
23. Thuerauf DJ, Hanford DS, &, Glembotski CC, (1994) Regulation of rat brain natriuretic peptide transcription. A potential role for GATA-related transcription factors in myocardial cell gene expression. J Biol Chem 269, 17772-17775.
24. Cameron V, Aitken G, Ellmers L, Kennedy M, &, Espiner E, (1996) The sites of gene expression of atrial, brain, and C-type natriuretic peptides in mouse fetal development: temporal changes in embryos and placenta. Endocrinology 137, 817-824. (Pubitemid 26070361)
25. Ogawa Y, Nakao K, Nakagawa O, Komatsu Y, Hosoda K, Suga S, Arai H, Nagata K, Yoshida N, &, Imura H, (1992) Human C-type natriuretic peptide. Characterization of the gene and peptide. Hypertension 19, 809-813.
26. Suga S, Nakao K, Itoh H, Komatsu Y, Ogawa Y, Hama N, &, Imura H, (1992) Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta: possible existence of vascular natriuretic peptide system. J Clin Invest 90, 1145-1149.
27. Hagiwara H, Sakaguchi H, Itakura M, Yoshimoto T, Furuya M, Tanaka S, &, Hirose S, (1994) Autocrine regulation of rat chondrocyte proliferation by natriuretic peptide C and its receptor, natriuretic peptide receptor-B. J Biol Chem 269, 10729-10733. (Pubitemid 24198280)
28. Wu C, Wu F, Pan J, Morser J, &, Wu Q, (2003) Furin-mediated processing of Pro-C-type natriuretic peptide. J Biol Chem 278, 25847-25852. (Pubitemid 36835344)
29. Schulz-Knappe P, Forssmann K, Herbst F, Hock D, Pipkorn R, &, Forssmann WD, (1988) Isolation and structural analysis of urodilatin, a new peptide of the cardiodilatin (ANP)-family extracted from human urine. Klin Wochenschr 66, 752-759.
30. Feller SM, Mägert HJ, Schulz-Knappe P, &, Forssmann WG, (1990) Urodilatin (hANF 95-126)-characteristics of a new atrial natriuretic factor peptide. In Atrial Natriuretic Factor (, Struthers AD, ed.), pp. 209-226. Blackwell, Oxford.
31. Saxenhofer H, Roselli A, Weidmann P, Forssmann WG, Bub A, Ferrari P, &, Shaw SG, (1990) Urodilatin, a natriuretic factor from kidneys can modify renal and cardiovascular function in men. Am J Physiol 259, F832-F838. (Pubitemid 20385701)
32. Schweitz H, Vigne P, Moinier D, Frelin CH, &, Lazdunski M, (1992) A new member of the natriuretic peptide family is present in the venom of the green mamba (Dendroaspis angusticeps). J Biol Chem 267, 13928-13932.
33. Chinkers M, Garbers DL, Chang MS, Lowe DG, Chin HM, Goeddel DV, &, Schulz S, (1989) A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor. Nature 338, 78-83. (Pubitemid 19076788)
34. Schulz S, Singh S, Bellet RA, Singh G, Tubb DJ, Chin H, &, Garbers DL, (1989) The primary structure of a plasma membrane guanylate cyclase demonstrates diversity within this new receptor family. Cell 58, 1155-1162. (Pubitemid 19238191)
35. Chang MS, Lowe DG, Lewis M, Hellmiss R, Chen E, &, Goeddel DV, (1989) Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclases. Nature 341, 68-72. (Pubitemid 19220660)
36. Pandey KN, &, Singh S, (1990) Molecular cloning and expression of murine guanylate cyclase/atrial natriuretic factor receptor cDNA. J Biol Chem 265, 12342-12348.
37. Garbers DL, (1992) Guanylyl cyclase receptors and their endocrine, paracrine, and autocrine ligands. Cell 71, 1-4.
38. Koller KJ, de Sauvage FJ, Lowe DG, &, Goeddel DV, (1992) Conservation of the kinaselike regulatory domain is essential for activation of the natriuretic peptide receptor guanylyl cyclases. Mol Cell Biol 12, 2581-2590.
39. Khurana ML, &, Pandey KN, (1993) Receptor-mediated stimulatory effect of atrial natriuretic factor, brain natriuretic peptide, and C-type natriuretic peptide on testosterone production in purified mouse Leydig cells: activation of cholesterol side-chain cleavage enzyme. Endocrinology 133, 2141-2149. (Pubitemid 23324720)
40. Fuller F, Porter JG, Arfsten AE, Miller J, Schilling JW, Scarborough RM, Lewicki JA, &, Schenk DB, (1988) Atrial natriuretic peptide clearance receptor. Complete sequence and functional expression of cDNA clones. J Biol Chem 263, 9395-9401.
41. Koller KJ, Lowe DG, Bennett GL, Minamino N, Kangawa K, Matsuo H, &, Goeddel DV, (1991) Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science 252, 120-123. (Pubitemid 21916951)
42. Misono KS, (2000) Atrial natriuretic factor binding to its receptor is dependent on chloride concentration: a possible feedback-control mechanism in renal salt regulation. Circ Res 86, 1135-1139. (Pubitemid 30396038)
43. Schulz S, (2005) C-type natriuretic peptide and guanylyl cyclase B receptor. Peptides 26, 1024-1034. (Pubitemid 40725373)
44. Fulle HJ, Vassar R, Foster DC, Yang RB, Axel R, &, Garbers DL, (1995) A receptor guanylyl cyclase expressed specifically in olfactory sensory neurons. Proc Natl Acad Sci USA 92, 3571-3575.
45. Yang RB, Foster DC, Garbers DL, &, Fulle HJ, (1995) Two membrane forms of guanylyl cyclase found in the eye. Proc Natl Acad Sci USA 92, 602-606.
46. Yu S, Avery L, Baude E, &, Garbers DL, (1997) Guanylyl cyclase expression in specific sensory neurons: a new family of chemosensory receptors. Proc Natl Acad Sci USA 94, 3384-3387. (Pubitemid 27157321)
47. Goraczniak RM, Duda T, Sitaramayya A, &, Sharma RK, (1994) Structural and functional characterization of the rod outer segment membrane guanylate cyclase. Biochem J 302 (Pt 2), 455-461. (Pubitemid 24280099)
48. Baude EJ, Arora VK, Yu S, Garbers DL, &, Wedel BJ, (1997) The cloning of a Caenorhabditis elegans guanylyl cyclase and the construction of a ligand-sensitive mammalian/nematode chimeric receptor. J Biol Chem 272, 16035-16039. (Pubitemid 27265588)
49. Hunter T, (1995) Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 80, 225-236.
50. Pandey KN, &, Kanungo J, (1993) Expression of extracellular ligand-binding domain of murine guanylate cyclase/atrial natriuretic factor receptor cDNA in Escherichia coli. Biochem Biophys Res Commun 190, 724-731. (Pubitemid 23207825)
51. Pandey KN, Kumar R, Li M, &, Nguyen H, (2000) Functional domains and expression of truncated atrial natriuretic peptide receptor-A: the carboxyl-terminal regions direct the receptor internalization and sequestration in COS-7 cells. Mol Pharmacol 57, 259-267. (Pubitemid 30084502)
52. Liu Y, Ruoho AE, Rao VD, &, Hurley JH, (1997) Catalytic mechanism of the adenylyl and guanylyl cyclases: modeling and mutational analysis. Proc Natl Acad Sci USA 94, 13414-13419. (Pubitemid 28009596)
53. Zhang G, Liu Y, Ruoho AE, &, Hurley JH, (1997) Structure of the adenylyl cyclase catalytic core. Nature 386, 247-253. (Pubitemid 27142504)
54. Sunahara RK, Beuve A, Tesmer JJ, Sprang SR, Garbers DL, &, Gilman AG, (1998) Exchange of substrate and inhibitor specificities between adenylyl and guanylyl cyclases. J Biol Chem 273, 16332-16338. (Pubitemid 28311412)
55. Tucker CL, Hurley JH, Miller TR, &, Hurley JB, (1998) Two amino acid substitutions convert a guanylyl cyclase, RetGC-1, into an adenylyl cyclase. Proc Natl Acad Sci USA 95, 5993-5997. (Pubitemid 28248952)
56. Misono KS, Philo JS, Arakawa T, Ogata CM, Qiu Y, Ogawa H, &, Young HS, (2011) Structure, signaling mechanism and regulation of the natriuretic peptide receptor guanylate cyclase. FEBS J 278, 1818-1829.
57. van den Akker F, Zhang X, Miyagi M, Huo X, Misono KS, &, Yee VC, (2000) Structure of the dimerized hormone-binding domain of a guanylyl-cyclase-coupled receptor. Nature 406, 101-104. (Pubitemid 30460220)
58. Misono KS, Ogawa H, Qiu Y, &, Ogata CM, (2005) Structural studies of the natriuretic peptide receptor: a novel hormone-induced rotation mechanism for transmembrane signal transduction. Peptides 26, 957-968. (Pubitemid 40725369)
59. De Lean A, McNicoll N, &, Labrecque J, (2003) Natriuretic peptide receptor A activation stabilizes a membrane-distal dimer interface. J Biol Chem 278, 11159-11166. (Pubitemid 36792670)
60. Anand-Srivastava MB, &, Trachte GJ, (1993) Atrial natriuretic factor receptors and signal transduction mechanisms. Pharmacol Rev 45, 455-497. (Pubitemid 24015112)
61. Pandey KN, (1992) Kinetic analysis of internalization, recycling and redistribution of atrial natriuretic factor-receptor complex in cultured vascular smooth-muscle cells. Ligand-dependent receptor down-regulation. Biochem J 288 (Pt 1), 55-61.
62. Anand-Srivastava MB, (2005) Natriuretic peptide receptor-C signaling and regulation. Peptides 26, 1044-1059. (Pubitemid 40725375)
63. Pandey KN, Pavlou SN, &, Inagami T, (1988) Identification and characterization of three distinct atrial natriuretic factor receptors. Evidence for tissue-specific heterogeneity of receptor subtypes in vascular smooth muscle, kidney tubular epithelium, and Leydig tumor cells by ligand binding, photoaffinity labeling, and tryptic proteolysis. J Biol Chem 263, 13406-13413.
64. Pandey KN, Nguyen HT, Sharma GD, Shi SJ, &, Kriegel AM, (2002) Ligand-regulated internalization, trafficking, and down-regulation of guanylyl cyclase/atrial natriuretic peptide receptor-A in human embryonic kidney 293 cells. J Biol Chem 277, 4618-4627. (Pubitemid 34968490)
65. Burczynska B, Duda T, &, Sharma RK, (2007) ATP signaling site in the ARM domain of atrial natriuretic factor receptor guanylate cyclase. Mol Cell Biochem 301, 93-107. (Pubitemid 46895149)
66. Garbers DL, &, Lowe DG, (1994) Guanylyl cyclase receptors. J Biol Chem 269, 30741-30744. (Pubitemid 24377548)
67. Sharma RK, (2010) Membrane guanylate cyclase is a beautiful signal transduction machine: overview. Mol Cell Biochem 334, 3-36.
68. Kurose H, Inagami T, &, Ui M, (1987) Participation of adenosine 5â-triphosphate in the activation of membrane-bound guanylate cyclase by the atrial natriuretic factor. FEBS Lett 219, 375-379.
69. Sharma RK, (2002) Evolution of the membrane guanylate cyclase transduction system. Mol Cell Biochem 230, 3-30. (Pubitemid 34257239)
70. Chinkers M, &, Garbers DL, (1989) The protein kinase domain of the ANP receptor is required for signaling. Science 245, 1392-1394. (Pubitemid 19252608)
71. Foster DC, &, Garbers DL, (1998) Dual role for adenine nucleotides in the regulation of the atrial natriuretic peptide receptor, guanylyl cyclase-A. J Biol Chem 273, 16311-16318. (Pubitemid 28311409)
72. Duda T, Goraczniak RM, &, Sharma RK, (1993) Core sequence of ATP regulatory module in receptor guanylate cyclases. FEBS Lett 315, 143-148. (Pubitemid 23015873)
73. Potter LR, &, Garbers DL, (1994) Protein kinase C-dependent desensitization of the atrial natriuretic peptide receptor is mediated by dephosphorylation. J Biol Chem 269, 14636-14642.
74. Kurose H, &, Lefkowitz RJ, (1994) Differential desensitization and phosphorylation of three cloned and transfected alpha 2-adrenergic receptor subtypes. J Biol Chem 269, 10093-10099. (Pubitemid 24196627)
75. Langlet C, Langer I, Vertongen P, Gaspard N, Vanderwinden JM, &, Robberecht P, (2005) Contribution of the carboxyl terminus of the VPAC1 receptor to agonist-induced receptor phosphorylation, internalization, and recycling. J Biol Chem 280, 28034-28043. (Pubitemid 41076921)
76. Huganir RL, &, Greengard P, (1990) Regulation of neurotransmitter receptor desensitization by protein phosphorylation. Neuron 5, 555-567.
77. Ballermann BJ, Marala RB, &, Sharma RK, (1988) Characterization and regulation by protein kinase C of renal glomerular atrial natriuretic peptide receptor-coupled guanylate cyclase. Biochem Biophys Res Commun 157, 755-761. (Pubitemid 19021244)
78. Duda T, &, Sharma RK, (1990) Regulation of guanylate cyclase activity by atrial natriuretic factor and protein kinase C. Mol Cell Biochem 93, 179-184. (Pubitemid 20127510)
79. Larose L, Rondeau JJ, Ong H, &, De Lean A, (1992) Phosphorylation of atrial natriuretic factor R1 receptor by serine/threonine protein kinases: evidence for receptor regulation. Mol Cell Biochem 115, 203-211.
80. Pandey KN, (1989) Stimulation of protein phosphorylation by atrial natriuretic factor in plasma membranes of bovine adrenal cortical cells. Biochem Biophys Res Commun 163, 988-994. (Pubitemid 19236947)
81. Barak LS, Tiberi M, Freedman NJ, Kwatra MM, Lefkowitz RJ, &, Caron MG, (1994) A highly conserved tyrosine residue in G protein-coupled receptors is required for agonist-mediated beta 2-adrenergic receptor sequestration. J Biol Chem 269, 2790-2795. (Pubitemid 24235781)
82. Pandey KN, Nguyen HT, Garg R, Khurana ML, &, Fink J, (2005) Internalization and trafficking of guanylyl (guanylate) cyclase/natriuretic peptide receptor A is regulated by an acidic tyrosine-based cytoplasmic motif GDAY. Biochem J 388, 103-113. (Pubitemid 40732937)
83. Pandey KN, (2009) Functional roles of short sequence motifs in the endocytosis of membrane receptors. Front Biosci 14, 5339-5360.
84. Nuglozeh E, Mbikay M, Stewart DJ, &, Legault L, (1997) Rat natriuretic peptide receptor genes are regulated by glucocorticoids in vitro. Life Sci 61, 2143-2155. (Pubitemid 27521197)
85. Fujio N, Gossard F, Bayard F, &, Tremblay J, (1994) Regulation of natriuretic peptide receptor A and B expression by transforming growth factor-beta 1 in cultured aortic smooth muscle cells. Hypertension 23, 908-913. (Pubitemid 24180836)
86. Gutkowska J, Jankowski M, Sairam MR, Fujio N, Reis AM, Mukaddam-Daher S, &, Tremblay J, (1999) Hormonal regulation of natriuretic peptide system during induced ovarian follicular development in the rat. Biol Reprod 61, 162-170. (Pubitemid 29295981)
87. Arise KK, &, Pandey KN, (2006) Inhibition and down-regulation of gene transcription and guanylyl cyclase activity of NPRA by angiotensin II involving protein kinase C. Biochem Biophys Res Commun 349, 131-135. (Pubitemid 44331772)
88. Garg R, &, Pandey KN, (2003) Angiotensin II-mediated negative regulation of Npr1 promoter activity and gene transcription. Hypertension 41, 730-736. (Pubitemid 36314583)
89. Kumar P, Bolden G, Arise KK, Krazit ST, &, Pandey KN, (2009) Regulation of natriuretic peptide receptor-A gene expression and stimulation of its guanylate cyclase activity by transcription factor Ets-1. Biosci Rep 29, 57-70.
90. Kumar P, &, Pandey KN, (2009) Cooperative activation of Npr1 gene transcription and expression by interaction of Ets-1 and p300. Hypertension 54, 172-178.
91. Haneda M, Kikkawa R, Maeda S, Togawa M, Koya D, Horide N, Kajiwara N, &, Shigeta Y, (1991) Dual mechanism of angiotensin II inhibits ANP-induced mesangial cGMP accumulation. Kidney Int 40, 188-194.
92. Bottari SP, King IN, Reichlin S, Dahlstroem I, Lydon N, &, de Gasparo M, (1992) The angiotensin AT2 receptor stimulates protein tyrosine phosphatase activity and mediates inhibition of particulate guanylate cyclase. Biochem Biophys Res Commun 183, 206-211.
93. Liang F, Schaufele F, &, Gardner DG, (2001) Functional interaction of NF-Y and Sp1 is required for type a natriuretic peptide receptor gene transcription. J Biol Chem 276, 1516-1522. (Pubitemid 32096586)
94. Pandey KN, (2010) Ligand-mediated endocytosis and intracellular sequestration of guanylyl cyclase/natriuretic peptide receptors: role of GDAY motif. Mol Cell Biochem 334, 81-98.
95. Rathinavelu A, &, Isom GE, (1991) Differential internalization and processing of atrial-natriuretic-factor B and C receptor in PC12 cells. Biochem J 276 (Pt 2), 493-497.
96. Pandey KN, Inagami T, &, Misono KS, (1986) Atrial natriuretic factor receptor on cultured Leydig tumor cells: ligand binding and photoaffinity labeling. Biochemistry 25, 8467-8472. (Pubitemid 17015184)
97. Pandey KN, (1993) Stoichiometric analysis of internalization, recycling, and redistribution of photoaffinity-labeled guanylate cyclase/atrial natriuretic factor receptors in cultured murine Leydig tumor cells. J Biol Chem 268, 4382-4390. (Pubitemid 23072983)
98. Pandey KN, (2001) Dynamics of internalization and sequestration of guanylyl cyclase/atrial natriuretic peptide receptor-A. Can J Physiol Pharmacol 79, 631-639. (Pubitemid 32745029)
99. Pandey KN, (2002) Intracellular trafficking and metabolic turnover of ligand-bound guanylyl cyclase/atrial natriuretic peptide receptor-A into subcellular compartments. Mol Cell Biochem 230, 61-72. (Pubitemid 34257242)
100. Pandey KN, (2005) Internalization and trafficking of guanylyl cyclase/natriuretic peptide receptor-A. Peptides 26, 985-1000. (Pubitemid 40725370)
101. Potter LR, (2011) Natriuretic peptide metabolism, clearance, and degradation. FEBS J 278, 1808-1817.
102. Brackmann M, Schuchmann S, Anand R, &, Braunewell KH, (2005) Neuronal Ca2+ sensor protein VILIP-1 affects cGMP signalling of guanylyl cyclase B by regulating clathrin-dependent receptor recycling in hippocampal neurons. J Cell Sci 118, 2495-2505. (Pubitemid 40873089)
103. Somanna NK, Arise KK, &, Pandey KN, (2007) Analysis of natriuretic peptide receptor A internalization by ribonucleic acid interference. J Am Investig Med 55, S262.
104. Oliver PM, Fox JE, Kim R, Rockman HA, Kim HS, Reddick RL, Pandey KN, Milgram SL, Smithies O, &, Maeda N, (1997) Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc Natl Acad Sci USA 94, 14730-14735. (Pubitemid 28041442)
105. Shi SJ, Vellaichamy E, Chin SY, Smithies O, Navar LG, &, Pandey KN, (2003) Natriuretic peptide receptor A mediates renal sodium excretory responses to blood volume expansion. Am J Physiol Renal Physiol 285, F694-F702. (Pubitemid 37140253)
106. Pandey KN, Oliver PM, Maeda N, &, Smithies O, (1999) Hypertension associated with decreased testosterone levels in natriuretic peptide receptor-A gene-knockout and gene-duplicated mutant mouse models. Endocrinology 140, 5112-5119.
107. John SW, Krege JH, Oliver PM, Hagaman JR, Hodgin JB, Pang SC, Flynn TG, &, Smithies O, (1995) Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 267, 679-681.
108. Kishimoto I, Dubois SK, &, Garbers DL, (1996) The heart communicates with the kidney exclusively through the guanylyl cyclase-A receptor: acute handling of sodium and water in response to volume expansion. Proc Natl Acad Sci USA 93, 6215-6219. (Pubitemid 26190830)
109. Shi SJ, Nguyen HT, Sharma GD, Navar LG, &, Pandey KN, (2001) Genetic disruption of atrial natriuretic peptide receptor-A alters renin and angiotensin II levels. Am J Physiol 281, F665-F673.
110. Melo LG, Veress AT, Ackermann U, Steinhelper ME, Pang SC, Tse Y, &, Sonnenberg H, (1999) Chronic regulation of arterial blood pressure in ANP transgenic and knockout mice: role of cardiovascular sympathetic tone. Cardiovasc Res 43, 437-444. (Pubitemid 29356382)
111. Steinhelper ME, Cochrane KL, &, Field LJ, (1990) Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes. Hypertension 16, 301-307. (Pubitemid 20313292)
112. Lin KF, Chao J, &, Chao L, (1995) Human atrial natriuretic peptide gene delivery reduces blood pressure in hypertensive rats. Hypertension 26, 847-853.
113. Schillinger KJ, Tsai SY, Taffet GE, Reddy AK, Marian AJ, Entman ML, Oka K, Chan L, &, O'Malley BW, (2005) Regulatable atrial natriuretic peptide gene therapy for hypertension. Proc Natl Acad Sci USA 102, 13789-13794. (Pubitemid 41377657)
114. Deschepper CF, Masciotra S, Zahabi A, Boutin-Ganache I, Picard S, &, Reudelhuber TL, (2001) Function alterations of the Nppa promoter are linked to cardiac ventricular hypertrophy in WKY/WKHA rat crosses. Circ Res 88, 223-228. (Pubitemid 32147312)
115. Zhao D, Vellaichamy E, Somanna NK, &, Pandey KN, (2007) Guanylyl cyclase/natriuretic peptide receptor-A gene disruption causes increased adrenal angiotensin II and aldosterone levels. Am J Physiol Renal Physiol 293, F121-F127. (Pubitemid 47345010)
116. Galet C, Min L, Narayanan R, Kishi M, Weigel NL, &, Ascoli M, (2003) Identification of a transferable two-amino-acid motif (GT) present in the C-terminal tail of the human lutropin receptor that redirects internalized G protein-coupled receptors from a degradation to a recycling pathway. Mol Endocrinol 17, 411-422. (Pubitemid 36315635)
117. Schreier B, Borner S, Volker K, Gambaryan S, Schafer SC, Kuhlencordt P, Gassner B, &, Kuhn M, (2008) The heart communicates with the endothelium through the guanylyl cyclase-A receptor: acute handling of intravascular volume in response to volume expansion. Endocrinology 149, 4193-4199.
118. Oliver PM, John SW, Purdy KE, Kim R, Maeda N, Goy MF, &, Smithies O, (1998) Natriuretic peptide receptor 1 expression influences blood pressures of mice in a dose-dependent manner. Proc Natl Acad Sci USA 95, 2547-2551. (Pubitemid 28145979)
119. Atarashi K, Mulrow PJ, Franco-Saenz R, Snajdar R, &, Rapp J, (1984) Inhibition of aldosterone production by an atrial extract. Science 224, 992-994. (Pubitemid 14105760)
120. Knowles JW, Esposito G, Mao L, Hagaman JR, Fox JE, Smithies O, Rockman HA, &, Maeda N, (2001) Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice. J Clin Invest 107, 975-984. (Pubitemid 32328002)
121. Klinger JR, Warburton RR, Pietras L, Oliver P, Fox J, Smithies O, &, Hill NS, (2002) Targeted disruption of the gene for natriuretic peptide receptor-A worsens hypoxia-induced cardiac hypertrophy. Am J Physiol Heart Circ Physiol 282, H58-H65. (Pubitemid 34654134)
122. Lopez MJ, Wong SK, Kishimoto I, Dubois S, Mach V, Friesen J, Garbers DL, &, Beuve A, (1995) Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide. Nature 378, 65-68.
123. Chen HH, &, Burnett JC Jr, (1999) The natriuretic peptides in heart failure: diagnostic and therapeutic potentials. Proc Assoc Am Physicians 111, 406-416. (Pubitemid 29446883)
124. Felker GM, Petersen JW, &, Mark DB, (2006) Natriuretic peptides in the diagnosis and management of heart failure. CMAJ 175, 611-617. (Pubitemid 44439724)
125. Reinhart K, Meisner M, &, Brunkhorst FM, (2006) Markers for sepsis diagnosis: what is useful? Crit Care Clin 22, 503-519. (Pubitemid 44163091)
126. Ellmers LJ, Scott NJ, Piuhola J, Maeda N, Smithies O, Frampton CM, Richards AM, &, Cameron VA, (2007) Npr1-regulated gene pathways contributing to cardiac hypertrophy and fibrosis. J Mol Endocrinol 38, 245-257. (Pubitemid 46351607)
127. Vellaichamy E, Zhao D, Somanna N, &, Pandey KN, (2007) Genetic disruption of guanylyl cyclase/natriuretic peptide receptor-A upregulates ACE and AT1 receptor gene expression and signaling: role in cardiac hypertrophy. Physiol Genomics 31, 193-202. (Pubitemid 350014397)
128. Xue H, Wang S, Wang H, Sun K, Song X, Zhang W, Fu C, Han Y, &, Hui R, (2008) Atrial natriuretic peptide gene promoter polymorphism is associated with left ventricular hypertrophy in hypertension. Clin Sci (Lond) 114, 131-137.
129. Tsutamoto T, Kanamori T, Morigami N, Sugimoto Y, Yamaoka O, &, Kinoshita M, (1993) Possibility of downregulation of atrial natriuretic peptide receptor coupled to guanylate cyclase in peripheral vascular beds of patients with chronic severe heart failure. Circulation 87, 70-75. (Pubitemid 23019335)
130. See R, &, de Lemos JA, (2006) Current status of risk stratification methods in acute coronary syndromes. Curr Cardiol Rep 8, 282-288. (Pubitemid 44043983)
131. Jaffe AS, Babuin L, &, Apple FS, (2006) Biomarkers in acute cardiac disease: the present and the future. J Am Coll Cardiol 48, 1-11. (Pubitemid 44202476)
132. Doust JA, Pietrzak E, Dobson A, &, Glasziou P, (2005) How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BWJ, 330, 330-625.
133. Khan IA, Fink J, Nass C, Chen H, Christenson R, &, deFilippi CR, (2006) N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients. Am J Cardiol 97, 1530-1534.
134. Zahabi A, Picard S, Fortin N, Reudelhuber TL, &, Deschepper CF, (2003) Expression of constitutively active guanylate cyclase in cardiomyocytes inhibits the hypertrophic effects of isoproterenol and aortic constriction on mouse hearts. J Biol Chem 278, 47694-47699. (Pubitemid 37523215)
135. Nakanishi M, Saito Y, Kishimoto I, Harada M, Kuwahara K, Takahashi N, Kawakami R, Nakagawa Y, Tanimoto K, Yasuno S, et al. (2005) Role of natriuretic peptide receptor guanylyl cyclase-A in myocardial infarction evaluated using genetically engineered mice. Hypertension 46, 441-447. (Pubitemid 41099182)
136. Ellmers LJ, Knowles JW, Kim HS, Smithies O, Maeda N, &, Cameron VA, (2002) Ventricular expression of natriuretic peptides in Npr1(-/-) mice with cardiac hypertrophy and fibrosis. Am J Physiol Heart Circ Physiol 283, H707-H714. (Pubitemid 34790866)
137. Scott NJ, Ellmers LJ, Lainchbury JG, Maeda N, Smithies O, Richards AM, &, Cameron VA, (2009) Influence of natriuretic peptide receptor-1 on survival and cardiac hypertrophy during development. Biochim Biophys Acta 1792, 1175-1184.
138. Li Y, Kishimoto I, Saito Y, Harada M, Kuwahara K, Izumi T, Takahashi N, Kawakami R, Tanimoto K, Nakagawa Y, et al. (2002) Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protective mechanism in the heart. Circulation 106, 1722-1728.
139. Kilic A, Bubikat A, Gassner B, Baba HA, &, Kuhn M, (2007) Local actions of atrial natriuretic peptide counteract angiotensin II stimulated cardiac remodeling. Endocrinology 148, 4162-4169. (Pubitemid 47295700)
140. Sabrane K, Kruse MN, Fabritz L, Zetsche B, Mitko D, Skryabin BV, Zwiener M, Baba HA, Yanagisawa M, &, Kuhn M, (2005) Vascular endothelium is critically involved in the hypotensive and hypovolemic actions of atrial natriuretic peptide. J Clin Invest 115, 1666-1674. (Pubitemid 40814676)
141. Alexander MR, Knowles JW, Nishikimi T, &, Maeda N, (2003) Increased atherosclerosis and smooth muscle cell hypertrophy in natriuretic peptide receptor A-/-apolipoprotein E-/- mice. Arterioscler Thromb Vasc Biol 23, 1077-1082. (Pubitemid 36713564)
142. Kishimoto I, Tokudome T, Nakao K, &, Kangawa K, (2011) The cardiovascular significance of the natriuretic peptide system. FEBS J, in press.
143. Tamura N, Doolittle LK, Hammer RE, Shelton JM, Richardson JA, &, Garbers DL, (2004) Critical roles of the guanylyl cyclase B receptor in endochondral ossification and development of female reproductive organs. Proc Natl Acad Sci USA 101, 17300-17305. (Pubitemid 39627814)
144. Bartels CF, Bukulmez H, Padayatti P, Rhee DK, van Ravenswaaij-Arts C, Pauli RM, Mundlos S, Chitayat D, Shih LY, Al-Gazali LI, et al. (2004) Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux. Am J Hum Genet 75, 27-34.
145. Cermak R, Kleta R, Forssmann WG, &, Schlatter E, (1996) Natriuretic peptides increase a K+ conductance in rat mesangial cells. Pflugers Arch 431, 571-577. (Pubitemid 26091702)
146. Light DB, Schwiebert EM, Karlson KH, &, Stanton BA, (1989) Atrial natriuretic peptide inhibits a cation channel in renal inner medullary collecting duct cells. Science 243, 383-385. (Pubitemid 19047514)
147. Nonoguchi H, Knepper MA, &, Manganiello VC, (1987) Effects of atrial natriuretic factor on cyclic guanosine monophosphate and cyclic adenosine monophosphate accumulation in microdissected nephron segments from rats. J Clin Invest 79, 500-507. (Pubitemid 17009686)
148. Appel RG, (1992) Growth-regulatory properties of atrial natriuretic factor. Am J Physiol 262, F911-F918.
149. Burnett JC Jr, Granger JP, &, Opgenorth TJ, (1984) Effects of synthetic atrial natriuretic factor on renal function and renin release. Am J Physiol 247, F863-F866. (Pubitemid 15178898)
150. Kurtz A, Della Bruna R, Pfeilschifter J, Taugner R, &, Bauer C, (1986) Atrial natriuretic peptide inhibits renin release from juxtaglomerular cells by a cGMP-mediated process. Proc Natl Acad Sci USA 83, 4769-4773. (Pubitemid 16075483)
151. von Geldern TW, Budzik GP, Dillon TP, Holleman WH, Holst MA, Kiso Y, Novosad EI, Opgenorth TJ, Rockway TW, Thomas AM, et al. (1990) Atrial natriuretic peptide antagonists: biological evaluation and structural correlations. Mol Pharmacol 38, 771-778.
152. Kumar R, Cartledge WA, Lincoln TM, &, Pandey KN, (1997) Expression of guanylyl cyclase-A/atrial natriuretic peptide receptor blocks the activation of protein kinase C in vascular smooth muscle cells. Role of cGMP and cGMP-dependent protein kinase. Hypertension 29, 414-421. (Pubitemid 27074077)
153. Zhao D, Pandey KN, &, Navar LG, (2010) ANP-mediated inhibition of distal nephron fractional sodium reabsorption in wild-type and mice overexpressing natriuretic peptide receptor. Am J Physiol Renal Physiol 298, F103-F108.
154. Cao L, Wu J, &, Gardner DG, (1995) Atrial natriuretic peptide suppresses the transcription of its guanylyl cyclase-linked receptor. J Biol Chem 270, 24891-24897.
155. Sharma GD, Nguyen HT, Antonov AS, Gerrity RG, von Geldern T, &, Pandey KN, (2002) Expression of atrial natriuretic peptide receptor-A antagonizes the mitogen-activated protein kinases (Erk2 and P38MAPK) in cultured human vascular smooth muscle cells. Mol Cell Biochem 233, 165-173. (Pubitemid 34746123)
156. Lincoln TM, Dey N, &, Sellak H, (2001) Invited review: cGMP-dependent protein kinase signaling mechanisms in smooth muscle: from the regulation of tone to gene expression. J Appl Physiol 91, 1421-1430. (Pubitemid 32803941)
157. Khurana ML, &, Pandey KN, (1996) Atrial natriuretic peptide inhibits the phosphoinositide hydrolysis in murine Leydig tumor cells. Mol Cell Biochem 158, 97-105. (Pubitemid 26187589)
158. Levin ER, &, Frank HJ, (1991) Natriuretic peptides inhibit rat astroglial proliferation: mediation by C receptor. Am J Physiol 261, R453-R457.
159. Chrisman TD, &, Garbers DL, (1999) Reciprocal antagonism coordinates C-type natriuretic peptide and mitogen-signaling pathways in fibroblasts. J Biol Chem 274, 4293-4299.
160. Wu CF, Bishopric NH, &, Pratt RE, (1997) Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes. J Biol Chem 272, 14860-14866. (Pubitemid 27251756)
161. Hutchinson HG, Trindade PT, Cunanan DB, Wu CF, &, Pratt RE, (1997) Mechanisms of natriuretic-peptide-induced growth inhibition of vascular smooth muscle cells. Cardiovasc Res 35, 158-167. (Pubitemid 27374753)
162. Prins BA, Weber MJ, Hu RM, Pedram A, Daniels M, &, Levin ER, (1996) Atrial natriuretic peptide inhibits mitogen-activated protein kinase through the clearance receptor. Potential role in the inhibition of astrocyte proliferation. J Biol Chem 271, 14156-14162.
163. Rose RA, &, Giles WR, (2008) Natriuretic peptide C receptor signalling in the heart and vasculature. J Physiol 586, 353-366.
164. Newton-Cheh C, Larson MG, Vasan RS, Levy D, Bloch KD, Surti A, Guiducci C, Kathiresan S, Benjamin EJ, Struck J, et al. (2009) Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure. Nat Genet 41, 348-353.
165. Rubattu S, Bigatti G, Evangelista A, Lanzani C, Stanzione R, Zagato L, Manunta P, Marchitti S, Venturelli V, Bianchi G, et al. (2006) Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension. J Am Coll Cardiol 48, 499-505. (Pubitemid 44093966)
166. Webber MA, &, Marder SR, (2008) Better pharmacotherapy for schizophrenia: what does the future hold? Curr Psychiatry Rep 10, 352-358.
167. Levy D, DeStefano AL, Larson MG, O'Donnell CJ, Lifton RP, Gavras H, Cupples LA, &, Myers RH, (2000) Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the Framingham Heart Study. Hypertension 36, 477-483.
168. Ji W, Foo JN, O'Roak BJ, Zhao H, Larson MG, Simon DB, Newton-Cheh C, State MW, Levy D, &, Lifton RP, (2008) Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat Genet 40, 592-599. (Pubitemid 351601207)
169. Lifton RP, Gharavi AG, &, Geller DS, (2001) Molecular mechanisms of human hypertension. Cell 104, 545-556. (Pubitemid 32201949)
170. Knowles JW, Erickson LM, Guy VK, Sigel CS, Wilder JC, &, Maeda N, (2003) Common variations in noncoding regions of the human natriuretic peptide receptor A gene have quantitative effects. Hum Genet 112, 62-70. (Pubitemid 36869117)